Diagnostic accuracy of AI-assisted chest radiographs in tuberculosis screening: A Ghanaian clinical study
PLOS One · 27.03.2026 · 21 (3) · e0342988
DOI: 10.1371/journal.pone.0342988 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 27.03.2026. Verfasst von Derick Seyram Sule und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiography, School of Biomedical and Allied Health Sciences (SBAHS), University of Ghana, Accra, Ghana. Hauptthemen laut MEDLINE: Radiography, Thoracic, Artificial Intelligence, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tuberculosis remains a major global health challenge, particularly in resource-limited settings where access to expert radiological interpretation is constrained. Artificial intelligence offers a promising solution to enhance diagnostic accuracy and efficiency in TB screening.
Aim
This study aimed to evaluate the diagnostic performance of an AI-based system compared to a radiologist in screening for TB using chest X-rays from 1,010 patients.
Methods
Patients were adults ≥18 years with suspected TB in a high-burden setting. GeneXpert MTB/RIF served as reference to assess accuracy, sensitivity, specificity, PPV, NPV, and AUC for radiologist and AI TB predictions. Comparisons used McNemar’s test and Cohen’s kappa to evaluate agreement and significance of differences.
Results
The AI system demonstrated superior performance with an accuracy of 91%, sensitivity of 86%, specificity of 93%, PPV of 85%, NPV of 94%, and AUC of 0.90. In contrast, the radiologist achieved an accuracy of 86%, sensitivity of 84%, specificity of 87%, PPV of 76%, NPV of 92%, and AUC of 0.86. McNemar’s test revealed a statistically significant difference between the two modalities (p = 0.0021). Cohen’s kappa indicated substantial agreement between AI and GeneXpert MTB/RIF result (κ = 0.79), moderate agreement for the radiologist and GeneXpert MTB/RIF result (κ = 0.69), and moderate agreement between radiologist and AI predictions (κ = 0.53).
Conclusion
The AI system outperformed the radiologist in TB screening, demonstrating higher diagnostic accuracy and agreement with GeneXpert MTB/RIF result. These findings support the integration of AI into TB screening workflows, particularly in settings with limited access to expert radiological interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiography, School of Biomedical and Allied Health Sciences (SBAHS), University of Ghana, Accra, Ghana.
- National Radiotherapy, Oncology and Nuclear Medicine Center (NRONMC), Korle Bu Teaching Hospital, Accra, Ghana.
- Department of Radiology, Korle Bu Teaching Hospital (KBTH), Accra, Ghana.
- Department of Radiology, School of Medicine, University of Health and Allied Sciences, Ho, Ghana.
- Department of Oncology, Cape Coast Teaching Hospital (CCTH), Cape Coast, Ghana.
ORCID-Profile: Klenam Dzefi-Tettey, Joseph Daniels, Andrew Yaw Nyantakyi
Zitieren
APA
Sule, D. S., Kyei, K. A., Antwi, W. K., Acquah, G., Dzefi-Tettey, K., Daniels, J., & Nyantakyi, A. Y. (2026). Diagnostic accuracy of AI-assisted chest radiographs in tuberculosis screening: A Ghanaian clinical study. PLOS One, 21(3), e0342988. https://doi.org/10.1371/journal.pone.0342988
Vancouver
Sule DS, Kyei KA, Antwi WK, Acquah G, Dzefi-Tettey K, Daniels J, et al. Diagnostic accuracy of AI-assisted chest radiographs in tuberculosis screening: A Ghanaian clinical study. PLOS One. 2026;21(3):e0342988. doi:10.1371/journal.pone.0342988
BibTeX
@article{Sule2026,
author = {Sule, Derick Seyram and Kyei, Kofi Adesi and Antwi, William Kwadwo and Acquah, Godwill and Dzefi-Tettey, Klenam and Daniels, Joseph and Nyantakyi, Andrew Yaw},
title = {Diagnostic accuracy of AI-assisted chest radiographs in tuberculosis screening: A Ghanaian clinical study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0342988},
doi = {10.1371/journal.pone.0342988}
}
EUVIMED